On November 22, 2024, the United States Securities and Exchange Commission (SEC) declared the effectiveness of Clene's S-3 form. This form, filed under the file number 333-283204, allows Clene to offer securities to the public, providing the company with flexibility in raising capital.The effectiveness of the S-3 form is a significant step for Clene, as it facilitates the company's ability to access public markets for potential future financing needs. This development may impact Clene's financial strategy and investor relations, given the increased opportunities for capital acquisition.Investors should monitor Clene's subsequent actions following this regulatory approval, as it may influence the company's market position and financial performance.

On November 22, 2024, the United States Securities and Exchange Commission (SEC) declared the effectiveness of Clene's S-3 form. This form, filed under the file number 333-283204, allows Clene to offer securities to the public, providing the company with flexibility in raising capital.The effectiveness of the S-3 form is a significant step for Clene, as it facilitates the company's ability to access public markets for potential future financing needs. This development may impact Clene's financial strategy and investor relations, given the increased opportunities for capital acquisition.Investors should monitor Clene's subsequent actions following this regulatory approval, as it may influence the company's market position and financial performance.